Oorsprong van het eerstegraads netwerk van Benjamin Hughes
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Services to the Health Industry | 25 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Benjamin Hughes via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member | |
| DISH NETWORK CORPORATION | Cable/Satellite TV | Director of Finance/CFO | |
| LIGHTPATH TECHNOLOGIES, INC. | Electronic Components | Director/Board Member | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| IMS HEALTH, INC. | Data Processing Services | Chief Executive Officer Director/Board Member Public Communications Contact General Counsel Chief Operating Officer | |
| AVAYA INC. | Packaged Software | Director/Board Member General Counsel | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
| CAREDX, INC | Medical Specialties | Director/Board Member | |
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member General Counsel | |
| ABBVIE INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
TPG Capital LLC
 TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Investment Managers | Private Equity Investor President | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
UCSF Foundation
 UCSF Foundation Investment Trusts/Mutual FundsMiscellaneous The UCSF Foundation promotes and supports the interests and welfare of the University of California San Francisco and the UCSF Medical Center. The UCSF Foundation’s daily operations are administered by a development staff responsible for major gifts, planned giving, corporate and foundation gifts, annual giving, development communications, alumni relations and campus events | Investment Trusts/Mutual Funds | Director/Board Member | |
Novotech (Australia) Pty Ltd.
 Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Biotechnology | Director/Board Member Chief Operating Officer | |
IQVIA RDS, Inc.
 IQVIA RDS, Inc. Miscellaneous Commercial ServicesCommercial Services IQVIA RDS, Inc. (North Carolina) provides solutions to the healthcare industry. The company was founded by Dennis B. Gillings in 1982 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | President General Counsel | |
| G.H. Besselaar Associates | Chief Tech/Sci/R&D Officer | ||
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Tarrant Capital IP LLC
 Tarrant Capital IP LLC Investment ManagersFinance Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA. | Investment Managers | Chief Investment Officer President | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer General Counsel | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
Precision Medicine Group LLC
 Precision Medicine Group LLC Miscellaneous Commercial ServicesCommercial Services Precision Medicine Group LLC engages in the provision of an integrated infrastructure that supports pharmaceutical and life sciences companies. It offers translational informatics and biometrics, specialty lab, biomaterials, oncology, and diagnostics and medical device solutions. The company was founded by Ethan D. Leder and Mark P. Clein in 2012 and is headquartered in Bethesda, MD. | Miscellaneous Commercial Services | Director/Board Member | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D’Angelo Partners Management LP(Tyree & D’Angelo Partners Management) is a private equity firm founded in 2013 by James L. Tyree, Enzo D’Angelo and Michael Tyree. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Vida Ventures LLC
 Vida Ventures LLC Investment ManagersFinance Vida Ventures LLC invests in companies located in the United States. The fund targets companies operating in the fields of life science innovation. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Founder | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder | |
| SYNEOS HEALTH, INC. | Biotechnology | Human Resources Officer Comptroller/Controller/Auditor | |
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology 3T Biosciences, Inc. operates as immunotherapy company. The company was founded by Luke J. Lee, Marvin Gee and Leah Sibener and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member | |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Acrostar Pharmaservices Corp. | Director/Board Member | ||
Novotech Holdings Pty Ltd.
 Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
Novotech Health Holdings Ltd.
 Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Biotechnology | Director/Board Member Chief Operating Officer | |
| Novotech Aus Holdco Pty Ltd. | Director/Board Member | ||
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 40 |
| Australië | 4 |
| Hongkong | 3 |
| Canada | 2 |
| China | 2 |
Sectoraal
| Health Technology | 21 |
| Commercial Services | 9 |
| Consumer Services | 6 |
| Finance | 6 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 208 |
| Corporate Officer/Principal | 66 |
| Independent Dir/Board Member | 44 |
| President | 27 |
| Chief Executive Officer | 23 |
Sterkste connecties
| Insiders | |
|---|---|
| John Danhakl | 75 |
| Fred Cohen | 58 |
| Todd Sisitsky | 37 |
| Ronald Rittenmeyer | 33 |
| Colleen Goggins | 20 |
| Jim Fasano | 19 |
| Michael McDonnell | 17 |
| John Leonard | 17 |
| Ari Bousbib | 17 |
| Eric Sherbet | 14 |
| James Berkshire | 13 |
| James Erlinger | 9 |
| Darcie Peck | 8 |
| W. Staub | 7 |
| James Hanson | 7 |
- Beurs
- Insiders
- Benjamin Hughes
- Bedrijfsconnecties
